Cargando…
Hedgehog/GLI signaling in tumor immunity - new therapeutic opportunities and clinical implications
Uncontrolled activation of the Hedgehog/Glioma-associated oncogene (HH/GLI) pathway is a potent oncogenic driver signal promoting numerous cancer hallmarks such as proliferation, survival, angiogenesis, metastasis and metabolic rewiring. Several HH pathway inhibitors have already been approved for m...
Autores principales: | Grund-Gröschke, Sandra, Stockmaier, Georg, Aberger, Fritz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933925/ https://www.ncbi.nlm.nih.gov/pubmed/31878932 http://dx.doi.org/10.1186/s12964-019-0459-7 |
Ejemplares similares
-
Casein Kinase 1D Encodes a Novel Drug Target in Hedgehog—GLI-Driven Cancers and Tumor-Initiating Cells Resistant to SMO Inhibition
por: Peer, Elisabeth, et al.
Publicado: (2021) -
Hedgehog/GLI signaling in hematopoietic development and acute myeloid leukemia—From bench to bedside
por: Tesanovic, Suzana, et al.
Publicado: (2022) -
Next-Generation Hedgehog/GLI Pathway Inhibitors for Cancer Therapy
por: Peer, Elisabeth, et al.
Publicado: (2019) -
Acute myeloid leukemia – strategies and challenges for targeting oncogenic Hedgehog/GLI signaling
por: Aberger, Fritz, et al.
Publicado: (2017) -
Epidermal activation of Hedgehog signaling establishes an immunosuppressive microenvironment in basal cell carcinoma by modulating skin immunity
por: Grund‐Gröschke, Sandra, et al.
Publicado: (2020)